Medical Clinical Notes
Open in Telegram
8 102
Subscribers
+324 hours
+107 days
+7430 days
Posts Archive
الصاحي يدخل والنايم راحت عليه ♥️🔥🏃♀
https://whatsapp.com/channel/0029VbAxzkoCBtxJ8vsKhz0Y
الصاحي يدخل والنايم راحت عليه ♥️🔥🏃♀
https://whatsapp.com/channel/0029VbAxzkoCBtxJ8vsKhz0Y
خسارة تدرس طب وما عندك هي القناة👇🏻🥼🩺
https://whatsapp.com/channel/0029VbAxzkoCBtxJ8vsKhz0Yاشترك قبل الحذف👆🏻
خسارة تدرس طب وما عندك هي القناة👇🏻🥼🩺
https://whatsapp.com/channel/0029VbAxzkoCBtxJ8vsKhz0Yاشترك قبل الحذف👆🏻
Repost from Clinical Practice guidelines
The new classification is simpler and more clinically actionable—but LVEF remains a continuous, variable measurement, so the 50% threshold should guide treatment 👉without replacing clinical phenotype, trajectory, congestion, biomarkers and underlying aetiology.
Repost from Clinical Practice guidelines
For treatment of Pseudomonas aeruginosa, the guidelines specify that ceftolozane-tazobactam (a preferred 👍👉agent for most resistant P. aeruginosa isolates)❌👉 is not active against Klebsiella pneumoniae 👉carbapenemase (KPC)-producing isolates
